Banka Bioloo Ltd (BANKA) — shareholding pattern, promoter holding, financials and share price
About Banka Bioloo Ltd (BANKA)
Banka Bioloo Ltd operates in the Industrial Products industry, within the Capital Goods sector. It trades on the NSE as BANKA and on the BSE under scrip code 535051. Its ISIN is INE862Y01015.
Incorporated in 2012, Banka Bioloo Ltd does manufacturing, supply, installation and O&M of Bio toilets and Controlled discharge toilet system [1]
Banka BioLoo Limited supplies sanitation, fecal sludge and wastewater treatment infrastructure across India, commercializing DRDO biodigester technology and delivering EPC, O&M, BOOT and HAM projects through two verticals: Banka Rail and Banka WaSH, with headquarters in Hyderabad and operations across seven railway zones and twenty‑two states, focused on scalable social impact.
Q3 FY25‑26 shows operational recovery: standalone revenue grew ~15% YoY to INR 15.93 crore while EBITDA swung positive to INR 0.90 crore standalone and INR 1.563 crore consolidated; PAT losses narrowed substantially, indicating improved cost control and higher WaSH execution contributing to margin recovery.
Listed peers in Industrial Products: Purple Wave Infocom Ltd, Meera Industries Ltd, Ducon Infratechnologies Ltd, Sellowrap Industries Ltd, Cenlub Industries Ltd, Forge Auto International Ltd.
Valuation & Returns
10 Jul 2026At ₹92.02 a share on 10 Jul 2026, Banka Bioloo Ltd (BANKA) was valued at a price-to-earnings ratio of 257.95x against an industry P/E of 48.01x and a price-to-book of 3.19x on a book value of ₹28.83 per share as of Mar 2025. Solomo computes return on equity of 1.24% and return on capital employed of 5.12% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 257.95x
- Industry P/E
- 48.01x
- P/B
- 3.19x
- EPS (TTM)
- ₹0.36
- Book value / share
- ₹28.83
- ROE
- 1.24%
- ROCE
- 5.12%
- ROA
- 0.47%
- Debt / equity
- 1.1x
- Dividend yield
- 0%
- EBITDA margin
- 10.84%
- 52-week range
- ₹41 – ₹97.88
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Banka Bioloo Ltd (BANKA) reported revenue of ₹57.09 crore, net profit of ₹0.39 crore and earnings per share of ₹0.32. That compares with revenue of ₹54.18 crore and net profit of ₹-8.91 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹17.67 crore and net profit ₹1.6 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 38.75 | 42.35 | 50 | 54.18 | 57.09 |
| Net profit (₹ cr) | 3.11 | 2.54 | -0.67 | -8.91 | 0.39 |
| EPS (₹) | 2.87 | 2.34 | -0.6 | -8.2 | 0.32 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 3.17% | 12.99% | 8.36% |
| Stock price CAGR | 7% | 10% | 27% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 52.02% of Banka Bioloo Ltd (BANKA) (down 0.05 pp QoQ). Market capitalisation was ₹101 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2018.
Largest disclosed public shareholders in Jun 2026: PRATIMA SURESH SHAH 5.03%, SURESH RAMNIKLAL SHAH 4.56%, HIMANSHU SURESH SHAH 4.18%, AKHILESH KUMAR TRIPATHI 3.68%, ABHISHEK RAJNIKANT SHETH 1.86%, DEBASHISH NEOGI 1.46%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 52.02% | - | - | - | - |
| Mar 2026 | 52.07% | - | - | - | - |
| Dec 2025 | 52.2% | - | - | - | - |
| Sep 2025 | 52.23% | - | - | - | - |
| Jun 2025 | 52.38% | - | - | - | - |
| Mar 2025 | 52.44% | - | - | - | - |
| Dec 2024 | 52.62% | - | - | - | - |
| Sep 2024 | 52.62% | - | - | - | - |